These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7385082)

  • 1. [Blood levels and effectiveness of beta-pyridyl carbinol in a new controlled release form in subjects with healthy metabolism and in patients with hyperlipoproteinemia II].
    Schulz E; Schräpler P
    Ther Umsch; 1980 Feb; 37(2):137-43. PubMed ID: 7385082
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-pyridyl-carbinol in the treatment of hyperlipoproteinemia].
    Kleiber G; Leickert KH
    ZFA (Stuttgart); 1979 Jul; 55(21):1199-205. PubMed ID: 157647
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of nicotinic alcohol therapy on serum lipoproteins in patients with hyperbetalipoproteinemia].
    Zanaboni L; Sommariva D; Bonfiglioli D; Fasoli A
    Clin Ter; 1983 Jun; 105(6):487-91. PubMed ID: 6617111
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and tolerance of a new sustained-release preparation of nicotinic alcohol for reduction of the atherosclerotic risk index].
    Bossini A; Pirro C; Barba C
    Clin Ter; 1984 Sep; 110(5):417-28. PubMed ID: 6238757
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
    Grodzińska L; Basista M; Byrska-Danek A; Kostka-Trabka E
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):879-81. PubMed ID: 6387654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic activity of a combination of nicotinyl alcohol, vitamin A and vitamin E in atherosclerotic arteriopathies].
    Putignano G
    Clin Ter; 1980 Aug; 94(3):275-82. PubMed ID: 7449347
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liapten--a new lipid depressor. Clinical experience in lipid metabolism disorders].
    Fodor GP
    ZFA (Stuttgart); 1978 Jan; 54(1):49-55. PubMed ID: 622856
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of baldness with beta-pyridyl-carbinol.
    HART VE; WILKINSON DS; ALLISON JF
    Br Med J; 1956 Jan; 1(4959):154. PubMed ID: 13276659
    [No Abstract]   [Full Text] [Related]  

  • 9. Unusual but reversible hepatic lesions following long-term treatment with pyridylcarbinol for familial hypercholesterolemia.
    Keller C; Zoller W; Wolfram G; Zöllner N
    Klin Wochenschr; 1988 Jul; 66(14):647-50. PubMed ID: 3062265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [STUDIES ON THE TREATMENT OF ENDOGENOUS HYPERLIPOPROTEINEMIA WITH BETA-PYRIDYL-CARBINOL].
    SCHOEN H; ZELLER W; HENNING N
    Klin Wochenschr; 1963 Nov; 41():1108-9. PubMed ID: 14109876
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of sound perception deafness with Danaden retard].
    Koeppel FW
    MMW Munch Med Wochenschr; 1976 Aug; 118(32-33):1015-6. PubMed ID: 822295
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb.
    Madej A; Okopien B; Kowalski J; Zielinski M; Wysocki J; Szygula B; Kalina Z; Herman ZS
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):345-9. PubMed ID: 9660044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of hypertriglyceridemia].
    Wollenweber J
    ZFA (Stuttgart); 1978 Feb; 54(6):349-53. PubMed ID: 636529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intramuscular application of acetylcholine in combination with beta-pyridyl carbinol (ronicol) in acute peripheral circulatory disorders].
    HEGER N
    Wien Med Wochenschr; 1955 Aug; 105(34):677-80. PubMed ID: 13257222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of serum lipids, blood coagulation factors, platelet aggregation, complement and serum immunoglobulins in a group of arteriosclerotic, hyperlipemic subjects treated with 3GS].
    D'Eredità F; Avellone G; Novo S; Davì G; Abruzzese G; Di Liberti M; Pinto A; Riolo F
    Clin Ter; 1981 Feb; 96(3):303-24. PubMed ID: 7307448
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood pharmacokinetics of fluorine in man after the oral administration of nicomethanol hydrofluoride].
    Cheymol G; Souleau M; Mahuzier G; Poitou P
    J Biol Buccale; 1984 Dec; 12(4):349-53. PubMed ID: 6597190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical testing of Danaden retard in functional psychoses from the aspect of slight to medium severe transient syndrome].
    Engelmann G
    Med Welt; 1975 Jul; 26(29-30):1380-4. PubMed ID: 1100984
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurophysiologic control during treatment of cerebral ischaemia with danaden retard (author's transl)].
    Klensch H; Hoffmann HR
    Med Klin; 1975 Jun; 70(26):1133-8. PubMed ID: 1223617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BETA-PYRIDYL-CARBINOL AND FIBRINOLYSIS].
    VOSS D
    Med Welt; 1963 Dec; 52():2700-3. PubMed ID: 14109241
    [No Abstract]   [Full Text] [Related]  

  • 20. [Etiroxate treatment for hyperlipoproteinaemia type IIa and IIb (author's transl)].
    Zadák Z; Kalinová M; Sobotka L
    Cas Lek Cesk; 1982 May; 121(19):593-5. PubMed ID: 7093991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.